Interleukin 17 is a chief orchestrator of immunity
暂无分享,去创建一个
[1] Ruth Gamble. Lineages , 2018, Oxford Scholarship Online.
[2] B. Silva-Santos,et al. IL-17+ γδ T cells as kick-starters of inflammation , 2017, Nature Immunology.
[3] S. Gaffen,et al. IL-17 Signaling: The Yin and the Yang. , 2017, Trends in immunology.
[4] Y. Belkaid,et al. On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier , 2017, Immunity.
[5] D. Gladman,et al. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1 , 2016, Annals of the rheumatic diseases.
[6] Quynh-Mai Pham,et al. IL-17A–producing resident memory γδ T cells orchestrate the innate immune response to secondary oral Listeria monocytogenes infection , 2016, Proceedings of the National Academy of Sciences.
[7] A. Kipnis,et al. The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis , 2016, Front. Microbiol..
[8] Ta-Chiang Liu,et al. Genetics and Pathogenesis of Inflammatory Bowel Disease. , 2016, Annual review of pathology.
[9] M. Veldhoen,et al. Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology , 2016, The Journal of Immunology.
[10] J. Koo,et al. Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials , 2016, Dermatology and Therapy.
[11] J. Koo,et al. Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials , 2016, Dermatology and Therapy.
[12] J. Kelsen,et al. Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells , 2016, Nature Medicine.
[13] P. Ho,et al. IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori , 2016, PloS one.
[14] I. McInnes,et al. Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases. , 2016, Annual review of medicine.
[15] M. Dougados,et al. Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. , 2015, The New England journal of medicine.
[16] Sabyasachi Das,et al. Characterization of Lamprey IL-17 Family Members and Their Receptors , 2015, The Journal of Immunology.
[17] Judy H. Cho,et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.
[18] Juan R. Cubillos-Ruiz,et al. ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis , 2015, Cell.
[19] T. Schoeb,et al. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis , 2015, Proceedings of the National Academy of Sciences.
[20] G. Ho. Faculty Opinions recommendation of Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. , 2015 .
[21] Simon C Watkins,et al. Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections , 2014, The Journal of experimental medicine.
[22] M. Veldhoen,et al. Cellular Plasticity of CD4+ T Cells in the Intestine , 2014, Front. Immunol..
[23] Sarah L. Gaffen,et al. The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing , 2014, Nature Reviews Immunology.
[24] F. Bernard,et al. Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1α, TNFα and Oncostatin M , 2014, PloS one.
[25] Yan Gao,et al. T cell-intrinsic role of IL-6 signaling in primary and memory responses , 2014, eLife.
[26] Henrique Veiga-Fernandes,et al. Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages , 2014, Cell.
[27] L. Bont,et al. Local IL-17A Potentiates Early Neutrophil Recruitment to the Respiratory Tract during Severe RSV Infection , 2013, PloS one.
[28] M. Veldhoen,et al. The aryl hydrocarbon receptor in innate T cell immunity , 2013, Seminars in Immunopathology.
[29] M. Oukka,et al. IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism , 2013, Mucosal Immunology.
[30] S. Orlow,et al. IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis , 2013, The Journal of investigative dermatology.
[31] N. Yosef,et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells , 2013, Nature.
[32] D. M. van der Heijde,et al. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial , 2013, Annals of the rheumatic diseases.
[33] R. D. Hatton,et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. , 2012, Immunity.
[34] Graham M Lord,et al. The Transcription Factor T-bet Regulates Intestinal Inflammation Mediated by Interleukin-7 Receptor+ Innate Lymphoid Cells , 2012, Immunity.
[35] Burkhard Becher,et al. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells , 2012, The Journal of experimental medicine.
[36] S. Rutz,et al. Regulation of epithelial immunity by IL-17 family cytokines. , 2012, Trends in immunology.
[37] Patrick Durez,et al. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study , 2012, Annals of the rheumatic diseases.
[38] Z. Yao,et al. IL-17A Synergizes with IFN-γ to Upregulate iNOS and NO Production and Inhibit Chlamydial Growth , 2012, PloS one.
[39] G. Newton,et al. IL-17 and TNF-α Sustain Neutrophil Recruitment during Inflammation through Synergistic Effects on Endothelial Activation , 2012, The Journal of Immunology.
[40] Marc Vandemeulebroecke,et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial , 2012, Gut.
[41] Jin-Young Park,et al. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. , 2012, Arthritis and rheumatism.
[42] J. Renauld,et al. IL-22 Mediates Host Defense against an Intestinal Intracellular Parasite in the Absence of IFN-γ at the Cost of Th17-Driven Immunopathology , 2012, The Journal of Immunology.
[43] T. Glant,et al. Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis , 2012, Arthritis Research & Therapy.
[44] S. Rutz,et al. Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in TH17 cells , 2011, Nature Immunology.
[45] S. Gaffen. Life before Seventeen: Cloning of the IL-17 Receptor , 2011, The Journal of Immunology.
[46] J. Renauld,et al. IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice , 2011, The Journal of Immunology.
[47] G. Semenza,et al. Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.
[48] J. O’Shea,et al. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. , 2011, Trends in immunology.
[49] D. Green,et al. HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.
[50] S. Travis,et al. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease , 2011, The Journal of experimental medicine.
[51] A. Skapenko,et al. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis , 2011, Annals of the rheumatic diseases.
[52] R. Caspi,et al. Faculty Opinions recommendation of Fate mapping of IL-17-producing T cells in inflammatory responses. , 2011 .
[53] M. Willart,et al. Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. , 2011, American journal of respiratory and critical care medicine.
[54] C. Bodemer,et al. Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity , 2011, Science.
[55] E. Hwang,et al. Prominent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+ T Cells in TallyHo/JngJ Mice , 2011, PloS one.
[56] S. Rutz,et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.
[57] S. Chimenti,et al. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. , 2011, The Journal of investigative dermatology.
[58] P. Miossec,et al. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes , 2011, Annals of the rheumatic diseases.
[59] W. Wilson,et al. A novel role for IL-22R1 as a driver of inflammation. , 2011, Blood.
[60] Todd Davidson,et al. Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.
[61] B. '. ’t Hart,et al. Effects of Early IL-17A Neutralization on Disease Induction in a Primate Model of Experimental Autoimmune Encephalomyelitis , 2010, Journal of Neuroimmune Pharmacology.
[62] B. Ryffel,et al. Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice. , 2010, The Journal of infectious diseases.
[63] A. Shafferman,et al. The Involvement of IL-17A in the Murine Response to Sub-Lethal Inhalational Infection with Francisella tularensis , 2010, PloS one.
[64] D. Artis,et al. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A , 2010, The Journal of experimental medicine.
[65] F. Bernard,et al. Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α Recapitulates Some Features of Psoriasis , 2010, The Journal of Immunology.
[66] M. Kawaguchi,et al. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta. , 2010, American journal of physiology. Renal physiology.
[67] J. D. Di Santo,et al. Th17 Cells Are the Dominant T Cell Subtype Primed by Shigella flexneri Mediating Protective Immunity , 2010, The Journal of Immunology.
[68] J. Alcorn,et al. Critical Role of IL-17RA in Immunopathology of Influenza Infection , 2009, The Journal of Immunology.
[69] R. Pawankar,et al. Synergistic Induction of Macrophage Inflammatory Protein-3α/CCL20 Production by Interleukin-17A and Tumor Necrosis Factor-α in Nasal Polyp Fibroblasts , 2009, The World Allergy Organization journal.
[70] M. Veldhoen,et al. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. , 2009, Immunity.
[71] M. Banerjee,et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. , 2009, Blood.
[72] Margarida Saraiva,et al. Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose , 2009, Immunity.
[73] Jianxu Li,et al. Erratum: Dual nature of the adaptive immune system in lampreys , 2009 .
[74] W. Zou,et al. Endogenous IL-17 contributes to reduced tumor growth and metastasis. , 2009, Blood.
[75] Hua Yu,et al. IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway , 2009, The Journal of experimental medicine.
[76] S. Gaffen. Structure and signalling in the IL-17 receptor family , 2009, Nature Reviews Immunology.
[77] Richard A Flavell,et al. A protective function for interleukin 17A in T cell–mediated intestinal inflammation , 2009, Nature Immunology.
[78] Brantley R. Herrin,et al. Dual Nature of the Adaptive Immune System in Lampreys , 2009, Nature.
[79] H. Volk,et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not , 2009, Journal of Molecular Medicine.
[80] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[81] J. Pober,et al. Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells , 2009, Circulation.
[82] R. Écochard,et al. Genome-Wide Comparison between IL-17A- and IL-17F-Induced Effects in Human Rheumatoid Arthritis Synoviocytes1 , 2009, The Journal of Immunology.
[83] S. Gaffen,et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis , 2009, The Journal of experimental medicine.
[84] J. Renauld,et al. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. , 2009, Arthritis and rheumatism.
[85] M. Veldhoen,et al. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells , 2009, The Journal of experimental medicine.
[86] C. Sasakawa,et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. , 2009, Immunity.
[87] O. Mandelboim,et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. , 2008, Immunity.
[88] S. Nakae,et al. The roles of IL‐17A in inflammatory immune responses and host defense against pathogens , 2008, Immunological reviews.
[89] M. Hashizume,et al. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. , 2008, Rheumatology.
[90] J. Kolls,et al. Cytokine-mediated regulation of antimicrobial proteins , 2008, Nature Reviews Immunology.
[91] Judy H. Cho,et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.
[92] V. Bronte. Th17 and cancer: friends or foes? , 2008, Blood.
[93] S. Tangye,et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.
[94] M. Leppert,et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. , 2008, The Journal of allergy and clinical immunology.
[95] S. Gaffen,et al. The Interleukin-17 Receptor Plays a Gender-Dependent Role in Host Protection against Porphyromonas gingivalis-Induced Periodontal Bone Loss , 2008, Infection and Immunity.
[96] R. Broaddus,et al. Regulation of inflammatory responses by IL-17F , 2008, The Journal of experimental medicine.
[97] M. Ostrowski,et al. Virus-Specific Interleukin-17-Producing CD4+ T Cells Are Detectable in Early Human Immunodeficiency Virus Type 1 Infection , 2008, Journal of Virology.
[98] J. Lord,et al. Prolonged, granulocyte–macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha , 2008, Arthritis research & therapy.
[99] S. Sa,et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.
[100] M. Fei,et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.
[101] J. Oakes,et al. IL‐17 receptor signaling influences virus‐induced corneal inflammation , 2008, Journal of leukocyte biology.
[102] Robert W. Williams,et al. Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.
[103] Lisa C. Zaba,et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses , 2007, The Journal of experimental medicine.
[104] B. Becher,et al. IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.
[105] F. Morel,et al. A role for T cell‐derived interleukin 22 in psoriatic skin inflammation , 2007, Clinical and experimental immunology.
[106] M. Veldhoen,et al. Th17 T cells: linking innate and adaptive immunity. , 2007, Seminars in immunology.
[107] P. Tak,et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. , 2007, Arthritis and rheumatism.
[108] C. Griffiths,et al. Pathogenesis and clinical features of psoriasis , 2007, The Lancet.
[109] N. Bostanci,et al. Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. , 2007, Microbial pathogenesis.
[110] Brigitta Stockinger,et al. Differentiation and function of Th17 T cells. , 2007, Current opinion in immunology.
[111] D. Jarrossay,et al. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.
[112] J. Ross,et al. Identification of an Interleukin 17F/17A Heterodimer in Activated Human CD4+ T Cells* , 2007, Journal of Biological Chemistry.
[113] S. Gaffen,et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. , 2007, Blood.
[114] J. Shellito,et al. Interleukin-23 (IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection , 2007, Infection and Immunity.
[115] R. Locksley,et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.
[116] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[117] Steven J. Schrodi,et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.
[118] Kathleen M. Smith,et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis , 2006, The Journal of experimental medicine.
[119] Y. Kadono,et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction , 2006, The Journal of experimental medicine.
[120] C. Uyttenhove,et al. Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis , 2006, European journal of immunology.
[121] L. Fouser,et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.
[122] J. Flynn,et al. IL-17 Production Is Dominated by γδ T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.
[123] R. J. Hocking,et al. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease , 2006, Nature Immunology.
[124] M. Neurath,et al. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. , 2006, Journal of immunology.
[125] Zihua Hu,et al. Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes* , 2006, Journal of Biological Chemistry.
[126] M. Veldhoen,et al. TGFbeta1, a "Jack of all trades": the link with pro-inflammatory IL-17-producing T cells. , 2006, Trends in immunology.
[127] J. Derry,et al. Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex , 2006, The Journal of Immunology.
[128] T. Mcclanahan,et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.
[129] J. Kolls,et al. Critical role of IL‐17 receptor signaling in acute TNBS‐induced colitis , 2006, Inflammatory bowel diseases.
[130] V. Lievin-Le Moal,et al. The Front Line of Enteric Host Defense against Unwelcome Intrusion of Harmful Microorganisms: Mucins, Antimicrobial Peptides, and Microbiota , 2006, Clinical Microbiology Reviews.
[131] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[132] R. D. Hatton,et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.
[133] L. Joosten,et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. , 2005, Arthritis and rheumatism.
[134] S. Khader,et al. IL-23 Compensates for the Absence of IL-12p70 and Is Essential for the IL-17 Response during Tuberculosis but Is Dispensable for Protection and Antigen-Specific IFN-γ Responses if IL-12p70 Is Available1 , 2005, The Journal of Immunology.
[135] J. Schwartzman,et al. Interleukin-17/Interleukin-17 Receptor-Mediated Signaling Is Important for Generation of an Optimal Polymorphonuclear Response against Toxoplasma gondii Infection , 2005, Infection and Immunity.
[136] R. Wu,et al. IL-17 Markedly Up-Regulates β-Defensin-2 Expression in Human Airway Epithelium via JAK and NF-κB Signaling Pathways1 , 2004, The Journal of Immunology.
[137] P. Schwarzenberger,et al. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.
[138] L. Joosten,et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. , 2004, Arthritis and rheumatism.
[139] Sarah L. Gaffen,et al. Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members* , 2004, Journal of Biological Chemistry.
[140] S. Nakae,et al. Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.
[141] Ann-Marie Broome,et al. S100 Protein Subcellular Localization During Epidermal Differentiation and Psoriasis , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[142] L. Joosten,et al. IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance 1 , 2003, The Journal of Immunology.
[143] A. Andoh,et al. Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.
[144] I. Homma,et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. , 2002, Immunity.
[145] A. Andoh,et al. IL-17 Selectively Down-Regulates TNF-α-Induced RANTES Gene Expression in Human Colonic Subepithelial Myofibroblasts1 , 2002, The Journal of Immunology.
[146] P. Schwarzenberger,et al. Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction , 2002, Inflammation Research.
[147] S. Deventer,et al. Contrasting roles of IL‐12p40 and IL‐12p35 in the development of hapten‐induced colitis , 2002, European journal of immunology.
[148] A. Gurney,et al. IL‐17: prototype member of an emerging cytokine family , 2002, Journal of leukocyte biology.
[149] R. Kelley,et al. IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor binding , 2001, The EMBO journal.
[150] J. Shellito,et al. Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.
[151] Karolina Palucka,et al. Linking innate and adaptive immunity , 1999, Nature Medicine.
[152] T. Martin,et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.
[153] J. Quach,et al. Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κB* , 1998, The Journal of Biological Chemistry.
[154] J. Banchereau,et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines , 1996, The Journal of experimental medicine.
[155] M. Seldin,et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. , 1995, Journal of immunology.
[156] F. Denizot,et al. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. , 1993, Journal of immunology.
[157] R. Panush. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2011 .
[158] 小椋 英樹,et al. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction , 2009 .
[159] André Reis,et al. Psoriasis is associated with increased β-defensin genomic copy number , 2008, Nature Genetics.
[160] 浜田 聡. IL-17A produced by γδ T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver , 2008 .
[161] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[162] R. Kastelein,et al. Understanding the IL-23-IL-17 immune pathway. , 2006, Trends in immunology.
[163] S. Takemura. Lymphoid neogenesis in rheumatoid synovitis , 2003 .
[164] J. Nelson,et al. The evolution of vertebrate antigen receptors: a phylogenetic approach. , 2000, Molecular biology and evolution.
[165] M. Veldhoen,et al. Interleukin-17-Producing gd T Cells Selectively Expand in Response to Pathogen Products and Environmental Signals , 2022 .